Search - tctmd.com

Displaying 41 - 52 of 52

Sort: Relevancy | Date

Big Downturn in CVD Procedures Seen During COVID-19’s First Wave

News Daily News

Big Downturn in CVD Procedures Seen During COVID-19’s First Wave

Michael O'Riordan

July 01, 2021

TCTMD’s Top 10 Most Popular Stories for March 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for March 2021

April 02, 2021

TCTMD’s Top 10 Most Popular Stories for January 2021

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2021

February 03, 2021

MR Improves in Half of Low-Flow/Low-Gradient AS Patients Undergoing TAVR

News Daily News

MR Improves in Half of Low-Flow/Low-Gradient AS Patients Undergoing TAVR

Michael O'Riordan

February 13, 2020

TCT Live Blog Day 2

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Two: Transcatheter Valves, New and Old

September 27, 2019

TCTMD’s Top 10 Most Popular Stories for July 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for July 2019

July 31, 2019

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

News Conference News TVT 2019

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Michael O'Riordan

June 20, 2019

NOTION and UK TAVI Report Good Long-term Function of Transcatheter Aortic Valves

News Daily News

NOTION and UK TAVI Report Good Long-term Function of Transcatheter Aortic Valves

February 06, 2019

TCTMD’s Top 10 Most Popular Stories for July 2018

News Daily News

TCTMD’s Top 10 Most Popular Stories for July 2018

August 01, 2018

Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition

News Daily News

Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition

Michael O'Riordan

January 26, 2018

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

News Conference News ACC 2017

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

Michael O'Riordan

March 19, 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

March 10, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.